Right ventricular dysfunction predicts outcome after transcatheter mitral valve repair for primary mitral valve regurgitation.
Philipp Maximilian DoldiLukas StolzDaniel KalbacherBenedikt KöllMartin GeyerSebastian LudwigMathias OrbanDaniel BraunLudwig T WeckbachThomas J StockerMichael NäbauerSatoshi HiguchiTobias RufJaqueline Da Rocha E SilvaMirjam WildNoemie TenceMatthias UnterhuberNiklas SchoferAniela PetrescuHolger ThielePhilipp LurzEdith LubosStephan von BardelebenNicole KaramDaryoush SamimJean-Michel ParadisChristos IliadisErion XhepaChristian HaglSteffen MassbergJörg Hausleiternull nullPublished in: European journal of heart failure (2022)
Mitral valve edge-to-edge repair is an effective treatment option for PMR patients. The presence of RVD is associated with less MR reduction, less symptomatic improvement and increased 2-year mortality. Accordingly, RVD might be included into pre-procedural prognostic considerations.
Keyphrases
- mitral valve
- end stage renal disease
- left atrial
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- oxidative stress
- magnetic resonance
- type diabetes
- cardiovascular disease
- cardiovascular events
- heart failure
- aortic stenosis
- patient reported outcomes
- coronary artery disease
- transcatheter aortic valve replacement